Brief: 3Sbio Says 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation By NMPA
17/04/2025 11:29
April 17 (Reuters) - 3SBio Inc 1530.HK: 707 INJECTION (ANTI-VEGF/PD-1 BISPECIFIC ANTIBODY) GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPA Further company coverage: 1530.HK ((Reuters.Briefs@thomsonreuters.com;))